Combined measurement of multiple acute phase reactants to predict relapse of rheumatoid arthritis

International Journal of Rheumatic Diseases

Volumn 18, Issue 7, 2015, Pages 725-730

  Lv, Fang ^a,b   Song, Li Jun ^a   Li, Xing Fu ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEOPLE S HOSPITAL OF RIZHAO   (China)

Author keywords

C reactive protein; Ferritin; Fibrinogen; Platelet; Rheumatoid arthritis

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FERRITIN; FIBRINOGEN; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DAS28; DISEASE ACTIVITY SCORE; FEMALE; FERRITIN BLOOD LEVEL; FIBRINOGEN BLOOD LEVEL; HUMAN; INFLAMMATORY DISEASE; KOLMOGOROV SMIRNOV TEST; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; ADOLESCENT; ARTHRITIS, RHEUMATOID; BLOOD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOMARKERS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84940787351     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12186     Document Type: Article

References (29)

1. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I (1991) Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146, 3032-7.
2. Arvidson NG, Larsson A, Larsen A (2002) Disease activity in rheumatoid arthritis: fibrinogen is superior to the erythrocyte sedimentation rate. Scand J Clin Lab Invest 62, 315-9.
3. Beyan E, Beyan C, Demirezer A, Ertugrul E, Uzuner A (2003) The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus. Scand J Rheumatol 32, 225-8.
4. Dessein PH, Joffe BI, Stanwix AE (2004) High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. J Rheumatol 31, 1095-7.
5. Yildirim K, Karatay S, Melikoglu MA, Gureser G, Ugur M, Senel K (2004) Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci 34, 423-6.
6. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38, 44-8.
7. Vercoutere W, Thevissen K, Bombardier C, Landewe RB (2011) Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl 87, 15-9.
8. Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-24.
9. van der Heijde DM, van 't Hof MA, van Riel PL, et al. (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49 (11), 916-20.
10. Pedrazzi AH (1998) Acute phase proteins: clinical and laboratory diagnosis. A review. Ann Pharm Fr 56 (3), 108-14.
11. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (6), 448-54.
12. Yildirim K, Erdal A, Karatay S, Melikoglu MA, Ugur M, Senel K (2004) Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis. South Med J 97 (4), 350-3.
13. Young B, Gleeson M, Cripps AW (1991) C-reactive protein: a critical review. Pathology 23, 118-24.
14. Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279, 48487-90.
15. Skogh T, Gustafsson D, Kjellberg M, Husberg M (2003) Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate. Ann Rheum Dis 62 (7), 681-2.
16. Semple JW, Freedman J (2010) Platelets and innate immunity. Cell Mol Life Sci 67, 499-511.
17. Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S (2010) The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21, 122-5.
18. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA (2002) Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 46, 1498-503.
19. Wang F, Wang NS, Yan CG, Li JH, Tang LQ (2007) The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 26, 768-71.
20. Palermo C, Maddali Bongi S, Bianucci G (1986) Relationship between serum ferritin, iron stores and disease activity in rheumatoid arthritis. Ric Clin Lab 16, 463-9.
21. Harrison PM, Arosio P (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275 (3), 161-203.
22. Fautrel B (2002) Ferritin levels in adult Still's disease: any sugar? Joint Bone Spine 69 (4), 355-7.
23. Furie B (2009) Pathogenesis of thrombosis. Hematol Am Soc Hematol Educ Program 2009, 255-8.
24. Loos BG (2005) Systemic markers of inflammation in periodontitis. J Periodontol 76 (Suppl 11), 2106-15.
25. Adams RA, Schachtrup C, Davalos D, Tsigelny I, Akassoglou K (2007) Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr Med Chem 14 (27), 2925-36.
26. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW (2004) Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50, 3444-9.
27. Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H (2008) Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin Rheumatol 27, 421-7.
28. Arvidsson NG, Gudbjornsson B, Hallgren R, Larsson A (1998) Concordant message of different inflammatory markers in patients with rheumatoid arthritis. Ups J Med Sci 103, 35-42.
29. Rooney T, Scherzer R, Shigenaga JK, Graf J, Imboden JB, Grunfeld C (2011) Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis. Rheumatology (Oxford) 50 (8), 458-65.